Elanco Animal Health Incorporated (ELAN)
NYSE · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $12.33B
- P/E ratio
- —
- EPS
- —
- Volume
- 3,666,104
- 52-week high
- —
- 52-week low
- —
- Open
- $25.91
- Day high
- $26.21
- Day low
- $25.11
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $4.72B | -$232M | -$0.47 |
| 2024 | $4.44B | $338M | $0.68 |
| 2023 | $4.42B | -$1.23B | -$2.50 |
| 2022 | $4.41B | -$78M | -$0.16 |
| 2021 | $4.76B | -$483M | -$0.99 |
About Elanco Animal Health Incorporated
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
- CEO
- Jeffrey N. Simmons
- Employees
- 9,000
- Country
- US
- IPO date
- Sep 20, 2018
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Elanco Animal Health Incorporated's stock price today?
- ELAN is trading at $25.14 as of Jul 20, 2026.
- What is Elanco Animal Health Incorporated's market cap?
- Elanco Animal Health Incorporated (ELAN) has a market capitalization of $12.33B.
- Does Elanco Animal Health Incorporated pay a dividend?
- Elanco Animal Health Incorporated did not pay a dividend in its most recent reported fiscal year.
- What sector is Elanco Animal Health Incorporated in?
- Elanco Animal Health Incorporated operates in the Healthcare sector.